Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Autophagy, a cellular degradation process mediated by Atg16L1, is linked to inflammation and inflammatory bowel disease.
• Atg16L1's role in immune regulation, particularly in the context of transplantation, requires further elucidation.

Purpose of the Study:

• To investigate the role of Atg16L1 in regulating graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT).
• To determine the impact of Atg16L1 deficiency on dendritic cell function and T cell responses in a GVHD mouse model.

Main Methods:

• Utilized a mouse model of allo-HSCT to induce GVHD.
• Assessed T cell proliferation, dendritic cell (DC) numbers, and costimulatory molecule expression in allo-HSCT recipients.
• Analyzed autophagy, lysosomal function, and A20 expression in DCs.

Main Results:

• Atg16L1 deficiency exacerbated GVHD in the allo-HSCT model.
• Increased T cell proliferation was observed in Atg16L1-deficient recipients, correlating with higher DC numbers and enhanced costimulatory molecule expression.
• Reduced autophagy in DCs was linked to lysosomal abnormalities and decreased A20, a negative regulator of DC activation.

Conclusions:

• Atg16L1 plays a crucial role in limiting DC-mediated inflammatory responses during GVHD.
• The autophagy pathway, through Atg16L1, influences DC activation and T cell responses, impacting GVHD severity.
• These findings expand the known functions of Atg16L1 and autophagy in immune regulation and inflammatory diseases.